University Hospital Antwerpen, Antwerp, Belgium; Femicare, Clinical Research for Women, Tienen, Belgium; Department of Obstetrics and Gynecology, Regional Hospital Heilig Hart, Tienen, Belgium.
Department of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical and Molecular Pathology, AML, Sonic Healthcare, Antwerp, Belgium.
Fertil Steril. 2022 Feb;117(2):287-296. doi: 10.1016/j.fertnstert.2021.10.022. Epub 2021 Dec 20.
To study the contagiousness of sperm and its influence on fertility after recovery from COVID-19 infection.
Prospective cohort study.
University medical center.
PATIENT(S): One hundred twenty Belgian men who had recovered from proven COVID-19 infection.
INTERVENTION(S): No intervention was performed.
MAIN OUTCOME MEASURE(S): Semen quality was assessed using the World Health Organisation criteria. DNA damage to sperm cells was assessed by quantifying the DNA fragmentation index and the high density stainability. Finally antibodies against SARS-CoV2 spike-1 antigen, nuclear and S1-receptor binding domain were measured by Elisa and chemilumenscent microparticle immunoassays, respectively.
RESULT(S): SARS-CoV-2 RNA was not detected in semen during the period shortly after infection nor at a later time. Mean progressive motility was reduced in 60% of men tested shortly (<1 month) after COVID-19 infection, 37% of men tested 1 to 2 months after COVID-19 infection, and 28% of men tested >2 months after COVID-19 infection. Mean sperm count was reduced in 37% of men tested shortly (<1 month) after COVID-19 infection, 29% of men tested 1 to 2 months after COVID-19 infection, and 6% of men tested >2 months after COVID-19 infection. The severity of COVID-19 infection and the presence of fever were not correlated with sperm characteristics, but there were strong correlations between sperm abnormalities and the titers of SARS-CoV-2 IgG antibody against spike 1 and the receptor- binding domain of spike 1, but not against nucleotide, in serum. High levels of antisperm antibodies developed in three men (2.5%).
CONCLUSION(S): Semen is not infectious with SARS-CoV-2 at 1 week or more after COVID-19 infection (mean, 53 days). However, couples with a desire for pregnancy should be warned that sperm quality after COVID-19 infection can be suboptimal. The estimated recovery time is 3 months, but further follow-up studies are under way to confirm this and to determine if permanent damage occurred in a minority of men.
研究 COVID-19 感染康复后精子的传染性及其对生育能力的影响。
前瞻性队列研究。
大学医学中心。
120 名比利时男性,均已从确诊的 COVID-19 感染中康复。
未进行干预。
使用世界卫生组织标准评估精液质量。通过量化精子 DNA 碎片化指数和高密度染色率来评估精子细胞的 DNA 损伤。最后,通过酶联免疫吸附法和化学发光微粒子免疫分析法分别测量针对 SARS-CoV2 刺突 1 抗原、核和 S1-受体结合域的抗体。
在感染后不久和之后的时间里,精液中均未检测到 SARS-CoV-2 RNA。在 COVID-19 感染后 1 个月内检测的 60%男性、1 至 2 个月内检测的 37%男性和 2 个月后检测的 28%男性中,精子前向运动能力降低。在 COVID-19 感染后 1 个月内检测的 37%男性、1 至 2 个月内检测的 29%男性和 2 个月后检测的 6%男性中,精子计数降低。COVID-19 感染的严重程度和发热与精子特征均无相关性,但精子异常与血清中针对刺突 1 的 SARS-CoV-2 IgG 抗体和刺突 1 受体结合域的滴度呈强相关性,而与核苷酸无相关性。3 名男性(2.5%)产生了高水平的抗精子抗体。
COVID-19 感染后 1 周或更长时间(平均 53 天),精液中没有 SARS-CoV-2 传染性。然而,对于有生育愿望的夫妇,应警告他们 COVID-19 感染后精子质量可能不佳。估计恢复期为 3 个月,但正在进行进一步的随访研究以确认这一点,并确定少数男性是否发生了永久性损伤。